BIOCRYST PHARM (BO1 MU) stock market data APIs
€8.2843
0(0%)
as of March 31, 2026
Try our APIs with
free plan!
BIOCRYST PHARM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BO1.MU.
Prev. Close
8.2843
Open
8.2854
High
8.2878
Low
8.2818
52 wk Range
5.274-9.954
Market Cap
1 856 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIOCRYST PHARM data using free add-ons & libraries
Get BIOCRYST PHARM Fundamental Data
BIOCRYST PHARM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIOCRYST PHARM News
New
BioCryst Shares Remain Undervalued, RBC Says
BioCryst Pharmaceuticals (BCRX) remains undervalued even with a recent price increase due to unconf PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
BioCryst (BCRX) Rallies 7.10% on Acquisition Buzz
BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) is one of the 10 Stocks Dominating Today’s Market Action. BioCryst grew its share prices by 7.10 percent on Thursday to close at $9.81 apiece as investors...
BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?
Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on BCRX. BioCryst Pha...
BioCryst Takeover Rumors Test Investor Focus On Fundamentals And Optionality
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Rumors of a potential acquisition of BioCryst Pharmaceuticals by a larger biopharmac...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
